Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Abdulrahim A, Adesola R (2022) Antimicrobial resistance in cholera: a need for quick intervention in Nigeria, West Africa. Int J Travel Med Glob Health 10(3):99–103
2. Baik YO, Choi SK, Olveda RM, Espos RA, Ligsay AD, Montellano MB et al (2015) A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines. Vaccine 33(46):6360–6365
3. Global Task Force on Cholera Control (2021) Use of cholera vaccine, Nigeria, 2021 [Internet]. https://www.gtfcc.org/wp-content/uploads/2022/01/8th-meeting-of-the-gtfcc-working-group-on-ocv-2021-day-1-james-onah.pdf. Cited 24 Jun 2024
4. Gulumbe B, Aminu U, Yusuf Z, Liman U, Faggo A, Abubakar J et al (2023) Cholera outbreaks in conflict-hit regions of Northern Nigeria: an overview. Afro-Egypt J Infect Endem Dis 13(2):134–142
5. Kabir S (2014) Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Alexander TS, editor. Clin Vaccine Immunol 21(9):1195–1205